Insulin resistance is an initial indicator of abnormal glucose homeostasis10, 11 and is a strong risk factor for diabetic complications12; thus, insulin sensitizers, including metformin, are used as the first‐line treatment for type 2 diabetes.13, 14. The gene discussed is INS; the disease is type 2 diabetes mellitus.